Latest Partnerships News

Bailador Technology Investments (ASX:BTI) posted a 64% drop in net profit to $6.9 million for FY26, amid a 55% fall in gains on financial assets. Despite this, the fund declared a fully franked 3.5 cent dividend and highlighted strong AI adoption and growth across its private tech portfolio.

Transurban's FY26 results reveal a sharp profit rise, robust traffic growth, and major infrastructure completions, alongside a landmark NSW toll reform deal.

EcoGraf has secured a binding term sheet with a major German graphite trader to double its Epanko graphite offtake to 40,000 tpa after five years, underpinning future expansions and project financing.

Corporate Travel Management (ASX:CTD) has locked in a five-year global partnership with Amadeus IT Group, aiming to accelerate its digital transformation and operational efficiency across multiple regions.

Cauldron Energy has begun trading on the US OTCQB market, broadening access to American investors without issuing new shares. This move taps into growing US demand for uranium, positioning Cauldron as a potential supplier from its Yanrey Uranium Project.

The Calmer Co. has pushed back the closing date of its $3.5 million renounceable entitlement offer to give shareholders more time to participate, including those overseas.

Horizon Oil has delivered a record FY26 production of 2.15 million barrels of oil equivalent and expanded its footprint to five countries following the Cue Energy takeover. The company’s diversified portfolio and disciplined capital management underpin a robust growth pipeline through 2028.

Karoon Energy's Who Dat East Joint Venture has given the green light to develop the Who Dat East field in the Gulf of America, aiming for production start in the second half of 2028 with attractive economics.

Elixir Energy has secured $5 million through a discounted placement to support ongoing flow tests at Lorelle-3H, artificial lift trials at Diona-1, and initiate a strategic review of its Taroom Trough assets.

Alterity Therapeutics has won a new US composition of matter patent for its lead drug ATH434, extending intellectual property protection to at least 2045 and boosting its commercial potential ahead of Phase 3 trials in Multiple System Atrophy.

Japan Australia Fluorite Associates has received a $3 million funding tranche under the $7.4 million IPCM grant, supporting the ongoing Definitive Feasibility Study for the Speewah Fluorite Project in Western Australia.

Premier Investments trims FY26 Premier Retail EBIT forecast to $176 million, citing tough trading conditions and announces exit from UK Peter Alexander stores while focusing on Australian growth and loyalty programs.